Pulmonary hypertension (PH) is a pathophysiological disorder that may involve multiple
clinical conditions and may be associated with a variety of cardiovascular and respiratory …

Pulmonary arterial hypertension (PAH) is a rare dyspnoea-fatigue syndrome caused by a
progressive increase in pulmonary vascular resistance and eventual right ventricular (RV) …

2022 ESC/ERS pulmonary hypertension guidelines incorporate changes and adaptations
focusing on clinical management https://bit. ly/3QtUvb4

Background Cardiac MRI measurements have diagnostic and prognostic value in the
evaluation of cardiopulmonary disease. Artificial intelligence approaches to automate …

Risk stratification has gained an increasing role in predicting outcomes and guiding the
treatment of patients with pulmonary arterial hypertension (PAH). The most predictive …

The contribution of the right ventricle (RV) to cardiac output is negligible in normal resting
conditions when pressures in the pulmonary circulation are low. However, the RV becomes …

Abstract Objectives The REPAIR (Right vEntricular remodeling in Pulmonary ArterIal
hypeRtension) study evaluated the effect of macitentan on right ventricular (RV) and …

Objectives To determine the prognostic value of patterns of right ventricular adaptation in
patients with pulmonary arterial hypertension (PAH), assessed using cardiac magnetic …

Abstract Purpose of Review The right ventricle (RV) has a complex geometry and physiology
which is distinct from the left. RV dysfunction and failure can be the aftermath of volume …

Erratum: 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension:
Developed by the task force for the diagnosis and treatment of pulmonary hypertension of the …